The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice

The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis

(2015) Yannick Waumans et al.   Frontiers in Immunology

Atherosclerotic Plaque Destabilization

(2014) Carlos Silvestre-Roig et al.   CIRCULATION RESEARCH

Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo

(2014) U. Forssmann et al.   JOURNAL OF IMMUNOLOGY

Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials

(2014) M. Monami et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors

(2013) M. Barbieri et al.   ATHEROSCLEROSIS

Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis

(2013) Veerle Matheeussen et al.   BASIC RESEARCH IN CARDIOLOGY

Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice

(2013) Nasib Ervinna et al.   ENDOCRINOLOGY

Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide’s anti-leukemic activity

(2013) P A Spagnuolo et al.   LEUKEMIA

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

(2013) Benjamin M. Scirica et al.   NEW ENGLAND JOURNAL OF MEDICINE

Animal Models of Atherosclerosis

(2012) Godfrey S. Getz et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Distribution of macrophage polarization markers in human atherosclerosis

(2012) J. Lauran Stöger et al.   ATHEROSCLEROSIS

Novel anti-inflammatory strategies in atherosclerosis

(2012) Fleur M. van der Valk et al.   CURRENT OPINION IN LIPIDOLOGY

A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation

(2012) Jixin Zhong et al.   DIABETES

A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation

(2012) Esther Pilla et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia

(2012) Peter Röhnert et al.   Journal of Neuroinflammation

A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice

(2012) Junichi Matsubara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of PKF275-055, a dipeptidyl peptidase–4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E–null mice

(2012) Michishige Terasaki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

(2012) Hal E Broxmeyer et al.   NATURE MEDICINE

Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis

(2011) Zubair Shah et al.   CIRCULATION

Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors

(2011) Veerle Matheeussen et al.   CLINICA CHIMICA ACTA

High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV

(2011) C. Marchetti et al.   DIABETOLOGIA

Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata

(2011) Chad E. Brokopp et al.   EUROPEAN HEART JOURNAL

Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors

(2011) Congyi Lu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

(2011) Nga N Ta et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Generation of Mature Murine Monocytes from Heterogeneous Bone Marrow and Description of Their Properties

(2011) Alexander Francke et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Structure–Activity Relationship Studies on Isoindoline Inhibitors of Dipeptidyl Peptidases 8 and 9 (DPP8, DPP9): Is DPP8-Selectivity an Attainable Goal?

(2011) Sebastiaan Van Goethem et al.   JOURNAL OF MEDICINAL CHEMISTRY

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

(2010) C. F. Deacon   DIABETES OBESITY & METABOLISM

Dipeptidyl peptidase expression during experimental colitis in mice

(2010) Roger Yazbeck et al.   INFLAMMATORY BOWEL DISEASES

Parthenolide sensitizes hepatocellular carcinoma cells to trail by inducing the expression of death receptors through inhibition of STAT3 activation

(2010) Daniela Carlisi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor

(2009) Jia-Jing Wu et al.   BIOCHEMICAL PHARMACOLOGY

Enzyme Activity and Immunohistochemical Localization of Dipeptidyl Peptidase 8 and 9 in Male Reproductive Tissues

(2009) Véronique Dubois et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions

(2009) Y.N. V. Gopal et al.   MOLECULAR CANCER THERAPEUTICS

In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma

(2008) Marco M. Jost et al.   BIOCHEMICAL PHARMACOLOGY